{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:46:10Z","timestamp":1793893570076,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:00:00Z","timestamp":1701475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013052","name":"Guangxi Medical and Health Key Research Project","doi-asserted-by":"publisher","award":["S201546"],"award-info":[{"award-number":["S201546"]}],"id":[{"id":"10.13039\/501100013052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018571","name":"Specific Research Project of Guangxi for Research Bases and Talents","doi-asserted-by":"publisher","award":["AD17129026"],"award-info":[{"award-number":["AD17129026"]}],"id":[{"id":"10.13039\/501100018571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018571","name":"Specific Research Project of Guangxi for Research Bases and Talents","doi-asserted-by":"publisher","award":["AD19245034"],"award-info":[{"award-number":["AD19245034"]}],"id":[{"id":"10.13039\/501100018571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2023GXNSFAA026243"],"award-info":[{"award-number":["2023GXNSFAA026243"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011785","name":"Guangxi Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007935","name":"Hainan Medical University","doi-asserted-by":"publisher","award":["XRC2022019"],"award-info":[{"award-number":["XRC2022019"]}],"id":[{"id":"10.13039\/501100007935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.biopha.2023.115987","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T20:31:22Z","timestamp":1701808282000},"page":"115987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertension"],"prefix":"10.1016","volume":"170","author":[{"given":"Shicheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwen","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8697-5484","authenticated-orcid":false,"given":"Honglian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6804-926X","authenticated-orcid":false,"given":"Mengxiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4282-6770","authenticated-orcid":false,"given":"Tongmeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2023.115987_bib1","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the american heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115987_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","article-title":"Heart failure with preserved ejection fraction: mechanisms and treatment strategies","volume":"73","author":"Omote","year":"2022","journal-title":"Annu Rev. Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.115987_bib3","first-page":"154","article-title":"Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction","volume":"9","author":"Wongsalap","year":"2023","journal-title":"Chronic Dis. Transl. Med."},{"issue":"36","key":"10.1016\/j.biopha.2023.115987_bib4","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2023.115987_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00638","article-title":"Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology","volume":"10","author":"Gevaert","year":"2019","journal-title":"Front Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115987_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ehf2.14167","article-title":"Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study","volume":"10","author":"Eidizadeh","year":"2023","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.biopha.2023.115987_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ejhf.67","article-title":"Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"16","author":"Gori","year":"2014","journal-title":"Eur. J. Heart Fail"},{"issue":"2","key":"10.1016\/j.biopha.2023.115987_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.mnh.0000203190.34643.d4","article-title":"Renal and vascular hypertension-induced inflammation: role of angiotensin II","volume":"15","author":"Ruiz-Ortega","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"8","key":"10.1016\/j.biopha.2023.115987_bib9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2021.12.009","article-title":"Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models","volume":"7","author":"van Ham","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115987_bib10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/cvr\/cvy038","article-title":"Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening","volume":"114","author":"Sorop","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"36","key":"10.1016\/j.biopha.2023.115987_bib11","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/eurheartj\/ehab499","article-title":"Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction","volume":"42","author":"Jackson","year":"2021","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.biopha.2023.115987_bib12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/HJH.0000000000002910","article-title":"Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension","volume":"39","author":"Kasiakogias","year":"2021","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.biopha.2023.115987_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41371-020-00407-1","article-title":"Salt sensitivity and hypertension","volume":"35","author":"Balafa","year":"2021","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"10.1016\/j.biopha.2023.115987_bib14","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/HYP.0000000000000047","article-title":"Salt sensitivity of blood pressure: a scientific statement from the american heart association","volume":"68","author":"Elijovich","year":"2016","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2023.115987_bib15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7150\/ijms.79741","article-title":"Salt restriction and angiotensin-converting enzyme inhibitor improve the responsiveness of the small artery in salt-sensitive hypertension","volume":"20","author":"Li","year":"2023","journal-title":"Int J. Med Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115987_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000498895","article-title":"High Sodium Intake Impairs Small Artery Vasoreactivity in vivo in Dahl Salt-Sensitive Rats","volume":"56","author":"Li","year":"2019","journal-title":"J. Vasc. Res"},{"issue":"6","key":"10.1016\/j.biopha.2023.115987_bib17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41401-022-01025-y","article-title":"Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling","volume":"44","author":"Wu","year":"2023","journal-title":"Acta Pharm. Sin."},{"issue":"18","key":"10.1016\/j.biopha.2023.115987_bib18","first-page":"e895","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.biopha.2023.115987_bib19","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/eurheartj\/ehab197","article-title":"Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies","volume":"42","author":"Hamdani","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2023.115987_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s40659-021-00342-6","article-title":"Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies","volume":"54","author":"Ramos-Kuri","year":"2021","journal-title":"Biol. Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.115987_bib21","first-page":"158","article-title":"Inflammation, immunity, and hypertension","volume":"49","author":"Agita","year":"2017","journal-title":"Acta Med Indones."},{"issue":"19","key":"10.1016\/j.biopha.2023.115987_bib22","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.3390\/ijms21197412","article-title":"p38 MAPK pathway in the heart: new insights in health and disease","volume":"21","author":"Romero-Becerra","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115987_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.683151","article-title":"Protective mechanism of humanin against oxidative stress in aging-related cardiovascular diseases","volume":"12","author":"Cai","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115987_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000256831.33459.ea","article-title":"p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage","volume":"49","author":"Park","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2023.115987_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3892\/ijmm.2015.2394","article-title":"The activation of p38 MAPK limits the abnormal proliferation of vascular smooth muscle cells induced by high sodium concentrations","volume":"37","author":"Wu","year":"2016","journal-title":"Int J. Mol. Med"},{"issue":"14","key":"10.1016\/j.biopha.2023.115987_bib26","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/CIRCULATIONAHA.119.043703","article-title":"Orphan G protein-coupled receptor GPRC5B controls smooth muscle contractility and differentiation by inhibiting prostacyclin receptor signaling","volume":"141","author":"Carvalho","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115987_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3858","article-title":"In silico analysis and verification of critical genes related to vascular calcification in multiple diseases","author":"Li","year":"2023","journal-title":"Cell Biochem. Funct."},{"issue":"1","key":"10.1016\/j.biopha.2023.115987_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054181","article-title":"BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"issue":"6613","key":"10.1016\/j.biopha.2023.115987_bib29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.abn0910","article-title":"Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure","volume":"377","author":"Cao","year":"2022","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.biopha.2023.115987_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115987_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.5","article-title":"ImageGP: An easy\u2010to\u2010use data visualization web server for scientific researchers","volume":"1","author":"Chen","year":"2022","journal-title":"iMeta"},{"issue":"W1","key":"10.1016\/j.biopha.2023.115987_bib32","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115987_bib33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10741-020-09913-3","article-title":"The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review","volume":"26","author":"Rabkin","year":"2021","journal-title":"Heart Fail Rev."},{"issue":"2","key":"10.1016\/j.biopha.2023.115987_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10741-021-10105-w","article-title":"Biomarkers for the diagnosis and management of heart failure","volume":"27","author":"Castiglione","year":"2022","journal-title":"Heart Fail Rev."},{"issue":"9","key":"10.1016\/j.biopha.2023.115987_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108087","article-title":"Lactate dehydrogenase a governs cardiac hypertrophic growth in response to hemodynamic stress","volume":"32","author":"Dai","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.biopha.2023.115987_bib36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/gerona\/glu210","article-title":"Increased age-related cardiac dysfunction in bradykinin B2 receptor-deficient mice","volume":"71","author":"Feng","year":"2016","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115987_bib37","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.4928","article-title":"Role of the central renin\u2011angiotensin system in hypertension (Review)","volume":"47","author":"Su","year":"2021","journal-title":"Int J. Mol. Med"},{"issue":"16","key":"10.1016\/j.biopha.2023.115987_bib38","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.1111\/jcmm.15579","article-title":"MD1 deletion exaggerates cardiomyocyte autophagy induced by heart failure with preserved ejection fraction through ROS\/MAPK signalling pathway","volume":"24","author":"Yang","year":"2020","journal-title":"J. Cell Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.115987_bib39","first-page":"391","article-title":"Sacubitril-Valsartan Ameliorates Heart Failure by Inhibiting Cardiac Remodeling Potentially via MAPK\/ERK Signaling","volume":"52","author":"Zhang","year":"2022","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/j.biopha.2023.115987_bib40","article-title":"Shexiang Tongxin dropping pill protects against chronic heart failure in mice via inhibiting the ERK\/MAPK and TGF-beta signaling pathways","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115987_bib41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1165\/rcmb.2016-0374OC","article-title":"p38 MAPK inhibition improves heart function in pressure-loaded right ventricular hypertrophy","volume":"57","author":"Kojonazarov","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115987_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20230018","article-title":"Progress and prospect of nanotechnology for cardiac fibrosis treatment","volume":"1","author":"Gaytan","year":"2023","journal-title":"Interdiscip. Med."},{"issue":"17","key":"10.1016\/j.biopha.2023.115987_bib43","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.7150\/thno.61875","article-title":"Pulmonary circulation-mediated heart targeting for the prevention of heart failure by inhalation of intrinsically bioactive nanoparticles","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223017857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223017857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:34:19Z","timestamp":1773966859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223017857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":43,"alternative-id":["S0753332223017857"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115987","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertension","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115987"}}